Zoflick-OZ Tablet

Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by disrupting DNA synthesis and causing cell death. This synergistic combination is particularly useful in managing mixed infections involving both aerobic and anaerobic pathogens, such as gastrointestinal infections, genitourinary tract infections, respiratory tract infections, and certain sexually transmitted infections.

Zoflick-OZ is prescribed based on susceptibility patterns and clinical judgment, with dosage adjusted according to the severity and site of infection. The tablet should be taken with adequate water, preferably after meals to minimize gastrointestinal discomfort. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, as well as in those with hepatic or renal impairment.

Potential adverse effects include gastrointestinal disturbances, dizziness, and hypersensitivity reactions. Complete the full course of therapy to prevent the development of resistance and ensure optimal therapeutic outcomes.